Yale Center for the Science of Cannabis and Cannabinoids YC-SCAN²
The Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²), established in 2023, was created to advance the understanding of cannabis and its derivatives, often referred to as cannabinoids, and how they are medically used. This innovative Center is a hub for groundbreaking research, dissemination of information, and education in the field of cannabis and cannabinoid science. Our mission is to conduct comprehensive research that uncovers the potential therapeutic applications of cannabis and cannabinoids, and to inform public policy based on our findings.
At YC-SCAN², we focus on thorough scientific research and strive to find science-based answers to critical questions concerning the potential medical benefits and risks associated with cannabis. As we continue to study cannabis science, we hope to revolutionize the understanding and utilization of cannabis and cannabinoids in healthcare. We are also dedicated to translating the knowledge we gain into helpful, practical applications that could enhance patient care and inform public policy.
The Center supports pilot projects from Yale-affiliated researchers, aiming to bridge the gap between basic and clinical research. These projects form the foundation for larger funding applications to NIH and other agencies. YC-SCAN² also encourages multidisciplinary studies into the effects of cannabis and cannabinoids, combining molecular neuroscience, genetics, electroencephalography, imaging, and psychopharmacology. We are deeply committed to training the next generation of scientists and clinicians to carry forward this important work in the emerging field of cannabis science.
ResearchOur research spectrum is broad and comprehensive, encompassing everything from a basic understand of cannabis and cannabinoids, to conducting advanced clinical trials exploring their potential benefits and risks.
Dissemination of InformationYC-SCAN² will independently and in partnership with other relevant organizations to provide regular updates to the scientific community and public.
YC-SCAN² will partner with existing training programs within the Yale Community to train fellows and postdocs in cannabis and cannabinoid research under the mentorship of Yale investigators with relevant expertise.
Deepak Cyril D’Souza, M.D., YC-SCAN² Director